We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 7,949 results
  1. Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease

    Many of the Alzheimer’s disease (AD) risk genes are specifically expressed in microglia and astrocytes, but how and when the genetic risk localizing...

    Hyun-Sik Yang, Ling Teng, ... Reisa A. Sperling in Nature Communications
    Article Open access 30 November 2023
  2. Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers

    Whether a relationship exists between cerebrovascular disease and Alzheimer’s disease has been a source of controversy. Evaluation of the temporal...

    Petrice M. Cogswell, Emily S. Lundt, ... Clifford R. Jack Jr in Nature Communications
    Article Open access 29 May 2023
  3. Compilation of reported protein changes in the brain in Alzheimer’s disease

    Proteomic studies of human Alzheimer’s disease brain tissue have potential to identify protein changes that drive disease, and to identify new drug...

    Manor Askenazi, Tomas Kavanagh, ... Eleanor Drummond in Nature Communications
    Article Open access 25 July 2023
  4. Cerebrovascular disease emerges with age and Alzheimer’s disease in adults with Down syndrome

    Adults with Down syndrome have a genetic form of Alzheimer’s disease (AD) and evidence of cerebrovascular disease across the AD continuum, despite...

    Patrick Lao, Natalie Edwards, ... Adam M. Brickman in Scientific Reports
    Article Open access 29 May 2024
  5. Deep Ensemble learning and quantum machine learning approach for Alzheimer’s disease detection

    Alzheimer disease (AD) is among the most chronic neurodegenerative diseases that threaten global public health. The prevalence of Alzheimer disease...

    Abebech Jenber Belay, Yelkal Mulualem Walle, Melaku Bitew Haile in Scientific Reports
    Article Open access 20 June 2024
  6. PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease

    We examined the role of protein tyrosine phosphatase receptor sigma (PTPRS) in the context of Alzheimer’s disease and synaptic integrity. Publicly...

    Alexandre Poirier, Cynthia Picard, ... Judes Poirier in Scientific Reports
    Article Open access 26 June 2024
  7. Metabolic phenoty** reveals an emerging role of ammonia abnormality in Alzheimer’s disease

    The metabolic implications in Alzheimer’s disease (AD) remain poorly understood. Here, we conducted a metabolomics study on a moderately aging...

    Tianlu Chen, Fengfeng Pan, ... Wei Jia in Nature Communications
    Article Open access 07 May 2024
  8. Plasma biomarkers predict Alzheimer’s disease before clinical onset in Chinese cohorts

    Plasma amyloid-β (Aβ)42, phosphorylated tau (p-tau)181, and neurofilament light chain (NfL) are promising biomarkers of Alzheimer’s disease (AD)....

    Huimin Cai, Yana Pang, ... Longfei Jia in Nature Communications
    Article Open access 24 October 2023
  9. Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction

    To uncover molecular changes underlying blood-brain-barrier dysfunction in Alzheimer’s disease, we performed single nucleus RNA sequencing in 24...

    Özkan İş, Xue Wang, ... Nilüfer Ertekin-Taner in Nature Communications
    Article Open access 20 June 2024
  10. A single-cell and spatial RNA-seq database for Alzheimer’s disease (ssREAD)

    Alzheimer’s Disease (AD) pathology has been increasingly explored through single-cell and single-nucleus RNA-sequencing (scRNA-seq & snRNA-seq) and...

    Cankun Wang, Diana Acosta, ... Qin Ma in Nature Communications
    Article Open access 06 June 2024
  11. Human whole-exome genotype data for Alzheimer’s disease

    The heterogeneity of the whole-exome sequencing (WES) data generation methods present a challenge to a joint analysis. Here we present a...

    Yuk Yee Leung, Adam C. Naj, ... Li-San Wang in Nature Communications
    Article Open access 23 January 2024
  12. Bearded capuchin monkeys as a model for Alzheimer’s disease

    The absence of a natural animal model is one of the main challenges in Alzheimer’s disease research. Despite the challenges of using nonhuman...

    Roberta Diehl Rodriguez, Maria Clotilde H. Tavares, ... Ricardo Nitrini in Scientific Reports
    Article Open access 15 March 2024
  13. Forecasting individual progression trajectories in Alzheimer’s disease

    The anticipation of progression of Alzheimer’s disease (AD) is crucial for evaluations of secondary prevention measures thought to modify the disease...

    Etienne Maheux, Igor Koval, ... Stanley Durrleman in Nature Communications
    Article Open access 10 February 2023
  14. APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia

    Several genetic risk factors for Alzheimer’s disease implicate genes involved in lipid metabolism and many of these lipid genes are highly expressed...

    Michael S. Haney, Róbert Pálovics, ... Tony Wyss-Coray in Nature
    Article Open access 13 March 2024
  15. Fatal iatrogenic cerebral β-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer’s disease

    We report the case of a 79-year-old woman with Alzheimer’s disease who participated in a Phase III randomized controlled trial called CLARITY-AD...

    Elena Solopova, Wilber Romero-Fernandez, ... Matthew Schrag in Nature Communications
    Article Open access 12 December 2023
  16. Single-cell-led drug repurposing for Alzheimer’s disease

    Alzheimer’s disease is the most common form of dementia. Notwithstanding the huge investments in drug development, only one disease-modifying...

    Silvia Parolo, Federica Mariotti, ... Enrico Domenici in Scientific Reports
    Article Open access 05 January 2023
  17. Multi-omic atlas of the parahippocampal gyrus in Alzheimer’s disease

    Alzheimer’s disease (AD) is the most common form of dementia worldwide, with a projection of 151 million cases by 2050. Previous genetic studies have...

    Claire Coleman, Minghui Wang, ... Panos Roussos in Scientific Data
    Article Open access 08 September 2023
  18. Functional variants identify sex-specific genes and pathways in Alzheimer’s Disease

    The incidence of Alzheimer’s Disease in females is almost double that of males. To search for sex-specific gene associations, we build a machine...

    Thomas Bourquard, Kwanghyuk Lee, ... Olivier Lichtarge in Nature Communications
    Article Open access 13 May 2023
  19. Neuron-level explainable AI for Alzheimer’s Disease assessment from fundus images

    Alzheimer’s Disease (AD) is a progressive neurodegenerative disease and the leading cause of dementia. Early diagnosis is critical for patients to...

    Nooshin Yousefzadeh, Charlie Tran, ... My T. Thai in Scientific Reports
    Article Open access 02 April 2024
  20. Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

    In Alzheimer’s disease, amyloid-beta (Aβ) triggers the trans-synaptic spread of tau pathology, and aberrant synaptic activity has been shown to...

    Nicolai Franzmeier, Amir Dehsarvi, ... Michael Schöll in Nature Communications
    Article Open access 03 January 2024
Did you find what you were looking for? Share feedback.